MicroB Antimicrobials Anti-Fungal Agents Flashcards
3 examples of Echinocandins are
1. […]
2. Micafungin
3. Anidulafungin
3 examples of Echinocandins are
1. Caspofungin
2. Micafungin
3. Anidulafungin
Remember that they work by inhibiting glucan synthase complex (needed for cell wall formation)
4 types of subcutaneous and systemic antifungal drugs -
1. […]
2. […]
3. […]
4. […]
The 3 types of cutaneous antifungal drugs
1. […]
2. […]
3. […]
4 types of subcutaneous and systemic antifungal drugs -
1. Amphotericin B (a polyene)
2. Flucytosine (an antimetabolite)
3. Caspofungin (an Echinocandin)
4. Triazoles (an Azole)
The 3 types of cutaneous antifungal drugs
1. Nystatin (a polyene)
2. Terbinafine (a squalene epoxidase inhibitor)
3. Imadazole (an Azole)
5-Flucytosine is usually used in combination with […] for treating
- […]
- […]
5-Flucytosine is usually used in combination with amphotericin B (works synergistically to allow the drug to penetrate the cell) for treating
- candidiasis (septicemia, endocarditis, UTI)
- cryptococcosis (meningitis and pulmonary infections)
Another reason is partly also to minimize resistance (resistance to 5-FC can develop due to decreased levels of ANY of the enzymes in the conversion of 5-FC to its metabolites) (or increased synthesis of cytosine)
5-Flucytosine works by inhibiting […] and […]
5-Flucytosine works by inhibiting protein synthesis and DNA synthesis
it is converted to
- 5-fluorouridine triphosphate (FUTP) and incorporated into fungal RNA in place of uridylic acid –> bye bye to protein synthesis
OR - 5-fluorodeoxyuridine monophosphate (FdUMP), inhibiting thymidylate synthase, a key enzyme for DNA synthesis –> bye bye to DNA synthesis~
5-FC enters fungal cells through cytosine specific permeases and is then converted, by cytosine deaminase, to its metabolically active form 5 fluorouracil (5-FU). Both proteins are absent in mammalian cells, however the conversion by gut bacteria and fungi of 5 FC to 5 FU can give rise to the adverse effects in the host
Administration of 5-flucytosine is by […]
Penetration to CSF: Excellent
Administration of 5-flucytosine is by orally
Penetration to CSF: Excellent
Adverse effect of 5-flucytosine (IMPT)
- […]
- […]
Adverse effect of 5-flucytosine (IMPT)
- Bone marrow suppression (very serious consequence)
- Hepatotoxicity (mild and reversible damage is common, monitor liver enzymes ALT and AST weekly)
Adverse effects of Amphotericin B
1. …
2. […]
3. Hypotension
4. Thrombophlebitis (adding heparin can alleviate this problem)
5. Bone marrow suppression
6. Ototoxicity
Adverse effects of Amphotericin B
1. Fever and chills (shake and bake syndrome)(common)
2. Nephrotoxicity
3. Hypotension
4. Thrombophlebitis (adding heparin can alleviate this problem)
5. Bone marrow suppression
6. Ototoxicity
Adverse effects of echinocandins
[…]
Adverse effects of echinocandins
MINIMAL yay! rarely leads to drug discontinuation…. but if you must name some…..
- GI related symptoms
- fever
- chills
- rashes
- skin flush
- thrombocytopenia
Adverse effects of terbinafine
1. GI disturbance
2. Headache
3. Rash
4. Herpatic failure
5. Exerbation of […]
Contraindication: DONT GIVE TO […]
Adverse effects of terbinafine
1. GI disturbance
2. Headache
3. Rash
4. Herpatic failure
5. Exerbation of autoimmune disease (SLE)
Contraindication: DONT GIVE TO Nursing mothers (it concentrates in breastmilk)
Amphotericin B is a naturally occuring […] antifungal and is effective used against […], […], […], […]
It is administered by
[…]
Amphotericin B is a naturally occuring polyene antifungal and is effective used against candida albicans, cryptococcus, aspergillus, histoplasmosis
It is administered by
Topical or IV infusion (negligible oral absorption)
TLDR, its useful against the medically important fungal infections
usually used alongside nystatin in a variety of oral formulation.
Amphotericin B is insoluble in water and must be coformulated with either
- […], or
- […]
The liposomal preparations have reduced […] toxicity but are […]
Amphotericin B is insoluble in water and must be coformulated with either
- Sodium Deoxycholate, or
- Artificial lipids to form liposomes
The liposomal preparations have reduced renal toxicity but are costly
Despite the low levels of the drug excreted in the urine, conventional amphotericin B (ie not the lipid formulations) causes renal vasoconstriction and can reduce the glomerular filtration rate by more than half.
Concurrent therapy with other nephrotoxic agents can increase the risk further. Renal function usually returns with discontinuation of the drug. Hydrate patients adequately (this seems to be the solution for most nephrotoxic drugs LOL)
Azoles can be split into 2 categories
1. Triazoles (given […] for […] infection)
2. Imidazoles (given […] for […] infection)
Azoles can be split into 2 categories
1. Triazoles (given **orally/IV **for systemic infection)
2. Imidazoles (given topically for cutaneous infection)
Predominantly fungistatic~
Caspofungin (a echinocandin) is one of the first line option for […] and second line option for […]:
Caspofungin (a echinocandin) is one of the first line option for candidiasis and second line option for invasive Aspergillosis (in patients who have failed or cannot tolerate amphotericin B or an azole):
DDI: All azoles are […], hence they enhance activity of drugs metabolised by CYP 450 including […]
DDI: All azoles are hepatic CYP450 3A4 isoenzyme inhibitors, hence they enhance activity of drugs metabolised by CYP 450 including warfarin, cyclosporine and oral hypoglycemic agents
Echinocandins are administered by […]
Echinocandins are administered by IV (lack oral bioavailability)
Undergo extensive protein binding (>97%) and are unable to penetrate into CSF